A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy

We describe a case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy (FAP) associated with Val30Met transthyretin mutation. A healthy 74-year-old woman noticed left blurred vision and floaters in 1992. Severe vitreous opacities were identified in the left eye. The patient displayed no systemic symptoms, and Congo red staining of the biopsy samples of the stomach and duodenum revealed no amyloid deposition. A diagnosis of FAP was confirmed following genetic investigation. Vitrectomy and cataract surgery was performed with intraocular lens implantation in April 1998. Histopathological examination of the vitreous material revealed amyloid fibrils. Intraocular pressure (IOP) gradually elevated and cupping of the optic disc enlarged. Trabeculectomy was performed in February 2000, but postoperative IOP was again elevated and a needling procedure was performed in March 2000. No postoperative recurrence of vitreous opacity has been reported and IOP has remained well controlled. In the present case, ocular manifestations were the only symptoms of FAP and systemic symptoms have not developed, after more than 12 years. FAP should be suspected as the cause in cases of vitreous opacities in patients from areas with endemic foci of FAP.

[1]  J. Garcia-Arumi,et al.  Vitreous amyloidosis without systemic or familial involvement , 2004, International Ophthalmology.

[2]  A. Negi,et al.  Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy. , 2003, American journal of ophthalmology.

[3]  Y. Ando,et al.  Ocular amyloid involvement after liver transplantation for polyneuropathy. , 2001, Annals of internal medicine.

[4]  M. Saraiva,et al.  Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: Ocular synthesis of mutant transthyretin , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[5]  Y. Ando,et al.  Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[6]  A. Negi,et al.  Ocular manifestations of familial amyloidotic polyneuropathy type I: long term follow up , 1997, The British journal of ophthalmology.

[7]  M. Skinner,et al.  A new transthyretin mutation associated with amyloidotic vitreous opacities. Asparagine for isoleucine at position 84. , 1992, Ophthalmology.

[8]  E. Schon,et al.  The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. , 1990, Investigative ophthalmology & visual science.

[9]  G. Holmgren,et al.  Restriction fragment length polymorphism analysis of mutated transthyretin in vitreous amyloidosis. , 1988, Archives of ophthalmology.

[10]  E. Schon,et al.  Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. , 1985, The Journal of biological chemistry.